Skip to main content

Table 1 Demographic data for both patient groups: acute kidney injury (AKI) and non-acute kidney injury (non-AKI)

From: Serum cystatin is a useful marker for the diagnosis of acute kidney injury in critically ill children: prospective cohort study

Variables

No. of patients

AKI

32 patients

Non-AKI

30 patients

P-value

Age (months)

18 (8–42)

20.5 (6–54)

0.05

Sex

 Male

19 (59.3 %)

16 (53.3 %)

0.79

 Female

13 (40.7 %)

14 (46.7 %)

RIFLE stage for AKI group

 RIFLE

18 (56.3 %)

  

 Injury

10 (31.25 %)

  

 Failure

4 (12.5 %)

  

Possible etiologies for AKI group (N = 32)

 Hypoxia/ischemia/ATN

13 (40.6 %)

  

 Sepsis

16 (50.0 %)

  

 Glomerulonephritis

2 (6.3 %)

  

 Urinary tract obstruction

1 (3.1 %)

  

 Nephrology consultation

13 (40.6 %)

  

 Diuretic use

23 (71.8 %)

  

 Renal replacement

1 (3.1 %)

  

Basal GFR (ml/min/1.73 m2) (median-interquartile range)

80 (66–96)

109 (79–124)

0.08

Basal creatinine (μmol/l) (median-interquartile range)

41.5 (31–51.2)

29.4 (24–34,4)

0.05

Basal cystatin C (mg/l) (median-interquartile range)

0.901.7 (0.802.5–1.502)

0.611.6 (0.549–0.672)

0.05

Mortality

4 (12.5 %)

1 (3.3 %)

0.114

Creatinine on discharge (μmol/l) (median-interquartile range)

28.0 (23–35)

28.72 (24–34.2)

0.832

GFR at discharge (ml/min/1.73 m2) (median-interquartile range)

102.5 (82.5–114.5)

104.7 (84–120)

0.535